• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降香挥发油在芪参益气滴丸心脏保护作用中的关键传递者角色

A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi.

机构信息

Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Research and Development Center of CM, Tianjin International Joint Academy of Biotechnology & Medicine, Tianjin, China.

出版信息

Sci Rep. 2017 Aug 4;7(1):7353. doi: 10.1038/s41598-017-07659-x.

DOI:10.1038/s41598-017-07659-x
PMID:28779167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5544742/
Abstract

Component-based Chinese medicine (CCM) is derived from traditional Chinese medicine but produced with modern pharmaceutical standard and clearer clinical indications. However, it still faces challenges of defining individual component contribution in the complex formula. Using QiShenYiQi (QSYQ) as a model CCM, we investigated the role of Dalbergia odorifera (DO), an herbal component, in preventing myocardial damage. We showed that in vitro, QSYQ exerted considerable protective activities on cardiomyocytes from HO-induced mitochondrial dysfunction with or without DO. However, in isolated rat hearts, myocardial protection by QSYQ was significantly weakened without DO. In everted gut sac model, DO significantly enhanced absorption of the major QSYQ ingredients in different regions of rat intestine. Finally, in in vivo mouse model of doxorubicin (DOX)-induced myocardial damage, only QSYQ, but not QiShenYiQi without DO (QSYQ-DO), exerted a full protection. Taken together, our results showed that instead of directly contributing to the myocardial protection, Dalbergia odorifera facilitates the major active ingredients absorption and increases their efficacy, eventually enhancing the in vivo potency of QSYQ. These findings may shed new lights on our understanding of the prescription compatibility theory, as well as the impacts of "courier herbs" in component-based Chinese medicine.

摘要

基于成分的中药(CCM)源自传统中药,但采用现代制药标准和更明确的临床适应症。然而,它仍然面临着在复杂配方中定义单个成分贡献的挑战。我们以参芪益气(QSYQ)为模型 CCM,研究了草药成分降香(DO)在预防心肌损伤中的作用。我们表明,在体外,QSYQ 对 HO 诱导的线粒体功能障碍具有相当大的保护作用,无论是否存在 DO。然而,在分离的大鼠心脏中,没有 DO 的情况下,QSYQ 的心肌保护作用明显减弱。在外翻肠囊模型中,DO 显著增强了 QSYQ 主要成分在大鼠肠不同区域的吸收。最后,在阿霉素(DOX)诱导的心肌损伤的体内小鼠模型中,只有 QSYQ,而不是没有 DO 的参芪益气(QSYQ-DO),发挥了全面的保护作用。总之,我们的结果表明,降香并不是直接有助于心肌保护,而是促进了主要活性成分的吸收,增加了它们的疗效,最终增强了 QSYQ 在体内的效力。这些发现可能为我们理解处方配伍理论以及“信使草药”在基于成分的中药中的作用提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/d2d6d914bbb1/41598_2017_7659_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/cd268d4c5af9/41598_2017_7659_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/1094786d7b1b/41598_2017_7659_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/ba83c4f95637/41598_2017_7659_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/73e155e91aa4/41598_2017_7659_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/546162e25bae/41598_2017_7659_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/d2d6d914bbb1/41598_2017_7659_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/cd268d4c5af9/41598_2017_7659_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/1094786d7b1b/41598_2017_7659_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/ba83c4f95637/41598_2017_7659_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/73e155e91aa4/41598_2017_7659_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/546162e25bae/41598_2017_7659_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cdc/5544742/d2d6d914bbb1/41598_2017_7659_Fig6_HTML.jpg

相似文献

1
A critical courier role of volatile oils from Dalbergia odorifera for cardiac protection in vivo by QiShenYiQi.降香挥发油在芪参益气滴丸心脏保护作用中的关键传递者角色
Sci Rep. 2017 Aug 4;7(1):7353. doi: 10.1038/s41598-017-07659-x.
2
An integrated evidence-based targeting strategy for determining combinatorial bioactive ingredients of a compound herbal medicine Qishen Yiqi dripping pills.一种综合基于证据的靶向策略,用于确定复方中药芪参益气滴丸的组合生物活性成分。
J Ethnopharmacol. 2018 Jun 12;219:288-298. doi: 10.1016/j.jep.2018.02.041. Epub 2018 Mar 20.
3
Metabonomic Strategy for the Evaluation of Chinese Medicine Salvia miltiorrhiza and Dalbergia odorifera Interfering with Myocardial Ischemia/Reperfusion Injury in Rats.基于代谢组学策略评价中药丹参和降香干预大鼠心肌缺血/再灌注损伤的作用
Rejuvenation Res. 2017 Aug;20(4):263-277. doi: 10.1089/rej.2016.1884. Epub 2017 Mar 7.
4
Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill® via ameliorate of multiple mitochondrial dysfunctions.芪参益气滴丸通过改善多种线粒体功能障碍对缺血/再灌注损伤起到心脏保护作用。
Drug Des Devel Ther. 2015 Jun 15;9:3051-66. doi: 10.2147/DDDT.S82146. eCollection 2015.
5
QiShenYiQi Pills ameliorates ischemia/reperfusion-induced myocardial fibrosis involving RP S19-mediated TGFβ1/Smads signaling pathway.芪参益气滴丸通过 RP S19 介导的 TGFβ1/Smads 信号通路改善缺血/再灌注诱导的心肌纤维化。
Pharmacol Res. 2019 Aug;146:104272. doi: 10.1016/j.phrs.2019.104272. Epub 2019 May 11.
6
QiShenYiQi dripping pill alleviates myocardial ischemia-induced ferroptosis via improving mitochondrial dynamical homeostasis and biogenesis.芪参益气滴丸通过改善线粒体动力学平衡和生物发生缓解心肌缺血诱导的铁死亡。
J Ethnopharmacol. 2023 May 23;308:116282. doi: 10.1016/j.jep.2023.116282. Epub 2023 Feb 18.
7
A network pharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action.一项关于中药芪参益气的网络药理学研究,以揭示其潜在的多成分、多靶点、多途径作用模式。
PLoS One. 2014 May 9;9(5):e95004. doi: 10.1371/journal.pone.0095004. eCollection 2014.
8
QiShenYiQi Pills® prevent cardiac ischemia-reperfusion injury via energy modulation.芪参益气滴丸®通过能量调节预防心肌缺血再灌注损伤。
Int J Cardiol. 2013 Sep 30;168(2):967-74. doi: 10.1016/j.ijcard.2012.10.042. Epub 2012 Nov 17.
9
QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode.芪参益气滴丸是一种中药复方制剂,通过多成分、多靶点模式预防压力超负荷诱导的心肌肥厚。
Sci Rep. 2015 Jul 2;5:11802. doi: 10.1038/srep11802.
10
Absorption, metabolism and effect of compatibility on absorption of qishenyiqi dropping pill.芪参益气滴丸的吸收、代谢及配伍对其吸收的影响
Biomed Chromatogr. 2014 Apr;28(4):554-63. doi: 10.1002/bmc.3069. Epub 2013 Oct 24.

引用本文的文献

1
Sugemule-7 alleviates oxidative stress, neuroinflammation, and cell death, promoting synaptic plasticity recovery in mice with postpartum depression.舒格缪尔-7可减轻氧化应激、神经炎症和细胞死亡,促进产后抑郁症小鼠的突触可塑性恢复。
Sci Rep. 2025 Jan 9;15(1):1426. doi: 10.1038/s41598-025-85276-9.
2
Qishen Yiqi Dripping Pills for Cardiovascular Diseases: Effects and Mechanisms.芪参益气滴丸治疗心脑血管疾病的作用及机制
Chin J Integr Med. 2023 Sep;29(9):857-864. doi: 10.1007/s11655-022-3288-2. Epub 2022 Oct 27.
3
Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model.

本文引用的文献

1
Effects and mechanisms of compound Chinese medicine and major ingredients on microcirculatory dysfunction and organ injury induced by ischemia/reperfusion.复方中药及其主要成分对缺血/再灌注引起的微循环功能障碍及器官损伤的作用及机制。
Pharmacol Ther. 2017 Sep;177:146-173. doi: 10.1016/j.pharmthera.2017.03.005. Epub 2017 Mar 16.
2
Astragaloside IV enhances cardioprotection of remote ischemic conditioning after acute myocardial infarction in rats.黄芪甲苷增强大鼠急性心肌梗死后远隔缺血预处理的心脏保护作用。
Am J Transl Res. 2016 Nov 15;8(11):4657-4669. eCollection 2016.
3
Rosmarinic Acid suppressed high glucose-induced apoptosis in H9c2 cells by ameliorating the mitochondrial function and activating STAT3.
半乳糖凝集素-3介导的炎症反应有助于益气益气方促进亚急性中风模型的神经功能恢复。
Front Pharmacol. 2021 Apr 19;12:588587. doi: 10.3389/fphar.2021.588587. eCollection 2021.
4
Correlation between Mitochondrial Dysfunction, Cardiovascular Diseases, and Traditional Chinese Medicine.线粒体功能障碍、心血管疾病与中医之间的关联
Evid Based Complement Alternat Med. 2020 Oct 7;2020:2902136. doi: 10.1155/2020/2902136. eCollection 2020.
5
Analysis of Flavonoids in by Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry.采用超高效液相色谱-串联质谱法分析 中的类黄酮。
Molecules. 2020 Jan 17;25(2):389. doi: 10.3390/molecules25020389.
迷迭香酸通过改善线粒体功能和激活信号转导与转录激活因子3(STAT3)来抑制高糖诱导的H9c2细胞凋亡。
Biochem Biophys Res Commun. 2016 Sep 2;477(4):1024-1030. doi: 10.1016/j.bbrc.2016.07.024. Epub 2016 Jul 8.
4
Danshensu alleviates cardiac ischaemia/reperfusion injury by inhibiting autophagy and apoptosis via activation of mTOR signalling.丹参素通过激活mTOR信号通路抑制自噬和凋亡,减轻心脏缺血/再灌注损伤。
J Cell Mol Med. 2016 Oct;20(10):1908-19. doi: 10.1111/jcmm.12883. Epub 2016 Jul 7.
5
Polypill: quo vadis?多效药丸:何去何从?
J Cardiovasc Med (Hagerstown). 2016 Nov;17(11):783-92. doi: 10.2459/JCM.0000000000000414.
6
Qishen Yiqi Drop Pill improves cardiac function after myocardial ischemia.芪参益气滴丸可改善心肌缺血后的心脏功能。
Sci Rep. 2016 Apr 14;6:24383. doi: 10.1038/srep24383.
7
Influence of Chitosan Nanoparticles as the Absorption Enhancers on Salvianolic acid B In vitro and In vivo Evaluation.壳聚糖纳米粒作为吸收促进剂对丹酚酸B的影响:体外和体内评价
Pharmacogn Mag. 2016 Jan-Mar;12(45):57-63. doi: 10.4103/0973-1296.176047.
8
YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α.益心舒,一种基于生脉散的中药配方,通过抑制线粒体介导的凋亡和上调肝脏X受体α来减轻心肌缺血/再灌注损伤。
Sci Rep. 2016 Mar 11;6:23025. doi: 10.1038/srep23025.
9
Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling.丹参素通过激活Akt/ERK1/2/Nrf2信号通路保护离体心脏免受缺血再灌注损伤。
Int J Clin Exp Med. 2015 Sep 15;8(9):14793-804. eCollection 2015.
10
Calycosin inhibits oxidative stress-induced cardiomyocyte apoptosis via activating estrogen receptor-α/β.毛蕊异黄酮通过激活雌激素受体-α/β抑制氧化应激诱导的心肌细胞凋亡。
Bioorg Med Chem Lett. 2016 Jan 1;26(1):181-5. doi: 10.1016/j.bmcl.2015.11.005. Epub 2015 Nov 4.